Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 215

1.

Pharmacological chaperones of ATP-sensitive potassium channels: Mechanistic insight from cryoEM structures.

Martin GM, Sung MW, Shyng SL.

Mol Cell Endocrinol. 2020 Feb 15;502:110667. doi: 10.1016/j.mce.2019.110667. Epub 2019 Dec 9. Review.

PMID:
31821855
2.

Full-length human cytomegalovirus terminase pUL89 adopts a two-domain structure specific for DNA packaging.

Theiß J, Sung MW, Holzenburg A, Bogner E.

PLoS Pathog. 2019 Dec 6;15(12):e1008175. doi: 10.1371/journal.ppat.1008175. eCollection 2019 Dec.

3.

First-in-Human Phase I Study of Fisogatinib (BLU-554) Validates Aberrant FGF19 Signaling as a Driver Event in Hepatocellular Carcinoma.

Kim RD, Sarker D, Meyer T, Yau T, Macarulla T, Park JW, Choo SP, Hollebecque A, Sung MW, Lim HY, Mazzaferro V, Trojan J, Zhu AX, Yoon JH, Sharma S, Lin ZZ, Chan SL, Faivre S, Feun LG, Yen CJ, Dufour JF, Palmer DH, Llovet JM, Manoogian M, Tugnait M, Stransky N, Hagel M, Kohl NE, Lengauer C, Sherwin CA, Schmidt-Kittler O, Hoeflich KP, Shi H, Wolf BB, Kang YK.

Cancer Discov. 2019 Dec;9(12):1696-1707. doi: 10.1158/2159-8290.CD-19-0555. Epub 2019 Oct 1.

PMID:
31575541
4.

Lung metastasis in adenoid cystic carcinoma of the head and neck.

Seok J, Lee DY, Kim WS, Jeong WJ, Chung EJ, Jung YH, Kwon SK, Kwon TK, Sung MW, Ahn SH.

Head Neck. 2019 Nov;41(11):3976-3983. doi: 10.1002/hed.25942. Epub 2019 Aug 29.

PMID:
31463986
5.

Correction: Urine protein:creatinine ratio vs 24-hour urine protein for proteinuria management: analysis from the phase 3 REFLECT study of lenvatinib vs sorafenib in hepatocellular carcinoma.

Evans TRJ, Kudo M, Finn RS, Han KH, Cheng AL, Ikeda M, Kraljevic S, Ren M, Dutcus CE, Piscaglia F, Sung MW.

Br J Cancer. 2019 Oct;121(7):625. doi: 10.1038/s41416-019-0534-2.

6.

Mechanism of pharmacochaperoning in a mammalian KATP channel revealed by cryo-EM.

Martin GM, Sung MW, Yang Z, Innes LM, Kandasamy B, David LL, Yoshioka C, Shyng SL.

Elife. 2019 Jul 25;8. pii: e46417. doi: 10.7554/eLife.46417.

7.

Urine protein:creatinine ratio vs 24-hour urine protein for proteinuria management: analysis from the phase 3 REFLECT study of lenvatinib vs sorafenib in hepatocellular carcinoma.

Evans TRJ, Kudo M, Finn RS, Han KH, Cheng AL, Ikeda M, Kraljevic S, Ren M, Dutcus CE, Piscaglia F, Sung MW.

Br J Cancer. 2019 Jul;121(3):218-221. doi: 10.1038/s41416-019-0506-6. Epub 2019 Jun 28. Erratum in: Br J Cancer. 2019 Jul 30;:.

8.

Prognostic value of the association between MHC class I downregulation and PD-L1 upregulation in head and neck squamous cell carcinoma patients.

Yoo SH, Keam B, Ock CY, Kim S, Han B, Kim JW, Lee KW, Jeon YK, Jung KC, Chung EJ, Kwon SK, Ahn SH, Sung MW, Heo DS.

Sci Rep. 2019 May 22;9(1):7680. doi: 10.1038/s41598-019-44206-2.

9.

Validation of a rhinologic virtual surgical simulator for performing a Draf 3 endoscopic frontal sinusotomy.

Won TB, Cho SW, Sung MW, Paek SH, Chan S, Salisbury K, Blevins NH, Vaisbuch Y, Hwang P.

Int Forum Allergy Rhinol. 2019 Aug;9(8):910-917. doi: 10.1002/alr.22333. Epub 2019 Apr 23.

PMID:
31012526
10.

Long-term oncological and functional outcomes of induction chemotherapy followed by (chemo)radiotherapy vs definitive chemoradiotherapy vs surgery-based therapy in locally advanced stage III/IV hypopharyngeal cancer: Multicenter review of 266 cases.

Chung EJ, Jeong WJ, Jung YH, Kwon SK, Kwon TK, Ahn SH, Sung MW, Keam B, Heo DS, Kim JH, Wu HG, Lee KW, Eom KY, Rho YS.

Oral Oncol. 2019 Feb;89:84-94. doi: 10.1016/j.oraloncology.2018.12.015. Epub 2018 Dec 27.

PMID:
30732965
11.

Poor prognostic factors in human papillomavirus-positive head and neck cancer: who might not be candidates for de-escalation treatment?

Yoo SH, Ock CY, Keam B, Park SJ, Kim TM, Kim JH, Jeon YK, Chung EJ, Kwon SK, Hah JH, Kwon TK, Jung KC, Kim DW, Wu HG, Sung MW, Heo DS.

Korean J Intern Med. 2019 Nov;34(6):1313-1323. doi: 10.3904/kjim.2017.397. Epub 2018 Nov 16.

12.

Optimal timing for salvage surgery after definitive radiotherapy in hypopharyngeal cancer.

Chun SJ, Keam B, Heo DS, Kim KH, Sung MW, Chung EJ, Kim JH, Jung KC, Kim JH, Wu HG.

Radiat Oncol J. 2018 Sep;36(3):192-199. doi: 10.3857/roj.2018.00311. Epub 2018 Sep 30.

13.

Genotypic characteristics and their association with phenotypic characteristics of hereditary medullary thyroid carcinoma in Korea.

Jung KY, Kim SM, Kim MJ, Cho SW, Kim BW, Lee YS, Jeong JJ, Nam KH, Chung WY, Lee KE, Chung EJ, Kim HJ, Park DJ, Sung MW, Park CS, Cho BY, Park YJ, Chang HS.

Surgery. 2018 Aug;164(2):312-318. doi: 10.1016/j.surg.2018.03.018. Epub 2018 May 17.

PMID:
29779869
14.

The chloroplast division protein ARC6 acts to inhibit disassembly of GDP-bound FtsZ2.

Sung MW, Shaik R, TerBush AD, Osteryoung KW, Vitha S, Holzenburg A.

J Biol Chem. 2018 Jul 6;293(27):10692-10706. doi: 10.1074/jbc.RA117.000999. Epub 2018 May 16.

15.

Classification for long-term survival in oligometastatic patients treated with ablative radiotherapy: A multi-institutional pooled analysis.

Hong JC, Ayala-Peacock DN, Lee J, Blackstock AW, Okunieff P, Sung MW, Weichselbaum RR, Kao J, Urbanic JJ, Milano MT, Chmura SJ, Salama JK.

PLoS One. 2018 Apr 12;13(4):e0195149. doi: 10.1371/journal.pone.0195149. eCollection 2018.

16.

Changes in programmed death-ligand 1 expression during cisplatin treatment in patients with head and neck squamous cell carcinoma.

Ock CY, Kim S, Keam B, Kim S, Ahn YO, Chung EJ, Kim JH, Kim TM, Kwon SK, Jeon YK, Jung KC, Kim DW, Wu HG, Sung MW, Heo DS.

Oncotarget. 2017 Jun 16;8(58):97920-97927. doi: 10.18632/oncotarget.18542. eCollection 2017 Nov 17.

17.

Chloroplast division protein ARC3 acts on FtsZ2 by preventing filament bundling and enhancing GTPase activity.

Shaik RS, Sung MW, Vitha S, Holzenburg A.

Biochem J. 2018 Jan 2;475(1):99-115. doi: 10.1042/BCJ20170697.

PMID:
29138260
18.

Correlation between computed tomography imaging and histopathology in pleomorphic adenoma of parotid gland.

Kim H, Kim SY, Kim YJ, Ko JM, Park MJ, Kim JH, Hah JH, Kwon TK, Kim KH, Sung MW.

Auris Nasus Larynx. 2018 Aug;45(4):783-790. doi: 10.1016/j.anl.2017.09.013. Epub 2017 Oct 18.

PMID:
29055657
19.

RISC-interacting clearing 3'- 5' exoribonucleases (RICEs) degrade uridylated cleavage fragments to maintain functional RISC in Arabidopsis thaliana.

Zhang Z, Hu F, Sung MW, Shu C, Castillo-González C, Koiwa H, Tang G, Dickman M, Li P, Zhang X.

Elife. 2017 May 2;6. pii: e24466. doi: 10.7554/eLife.24466.

20.

Human Adipose Tissue Derived Extracellular Matrix and Methylcellulose Hydrogels Augments and Regenerates the Paralyzed Vocal Fold.

Kim DW, Kim EJ, Kim EN, Sung MW, Kwon TK, Cho YW, Kwon SK.

PLoS One. 2016 Oct 21;11(10):e0165265. doi: 10.1371/journal.pone.0165265. eCollection 2016.

21.

Celecoxib enhances the inhibitory effect of 5-FU on human squamous cell carcinoma proliferation by ROS production.

Sung MW, Lee DY, Park SW, Oh SM, Choi JJ, Shin ES, Kwon SK, Ahn SH, Kim YH.

Laryngoscope. 2017 Apr;127(4):E117-E123. doi: 10.1002/lary.26309. Epub 2016 Sep 26.

PMID:
27666139
22.

Is There Any Age Cutoff to Treat Elderly Patients with Head and Neck Cancer? Comparing with Septuagenarians and Octogenarians.

Kim H, Kim SD, Shim YJ, Lee SY, Sung MW, Kim KH, Hah JH.

J Korean Med Sci. 2016 Aug;31(8):1300-6. doi: 10.3346/jkms.2016.31.8.1300. Epub 2016 May 16.

23.

Recurrence and Survival After Gross Total Removal of Resectable Undifferentiated or Poorly Differentiated Thyroid Carcinoma.

Lee DY, Won JK, Choi HS, Park do J, Jung KC, Sung MW, Kim KH, Hah JH, Park YJ.

Thyroid. 2016 Sep;26(9):1259-68. doi: 10.1089/thy.2016.0147. Epub 2016 Aug 11.

PMID:
27412715
25.

Prevention of anterior glottis web with hyaluronic acid derivatives in rabbit model.

Kwon SK, Ryu YJ, Kim DW, Chang H, Kim SY, Sung MW, Hah JH.

Laryngoscope. 2016 Oct;126(10):2320-4. doi: 10.1002/lary.26089. Epub 2016 Jun 16.

PMID:
27313151
26.

Antitumor effect of CXCR4 antagonist AMD3100 on the tumorigenic cell line of BHP10-3 papillary thyroid cancer cells.

Jung YH, Lee DY, Cha W, Kim BH, Sung MW, Kim KH, Ahn SH.

Head Neck. 2016 Oct;38(10):1479-86. doi: 10.1002/hed.24461. Epub 2016 Apr 7.

PMID:
27061747
27.

Induction chemotherapy in head and neck squamous cell carcinoma of the paranasal sinus and nasal cavity: a role in organ preservation.

Ock CY, Keam B, Kim TM, Han DH, Won TB, Lee SH, Hah JH, Kwon TK, Kim DW, Kim DY, Rhee CS, Wu HG, Sung MW, Heo DS.

Korean J Intern Med. 2016 May;31(3):570-8. doi: 10.3904/kjim.2015.020. Epub 2016 Mar 15.

28.

PD-L1 expression is associated with epithelial-mesenchymal transition in head and neck squamous cell carcinoma.

Ock CY, Kim S, Keam B, Kim M, Kim TM, Kim JH, Jeon YK, Lee JS, Kwon SK, Hah JH, Kwon TK, Kim DW, Wu HG, Sung MW, Heo DS.

Oncotarget. 2016 Mar 29;7(13):15901-14. doi: 10.18632/oncotarget.7431.

29.

Predictive and prognostic value of PET/CT imaging post-chemoradiotherapy and clinical decision-making consequences in locally advanced head & neck squamous cell carcinoma: a retrospective study.

Kim R, Ock CY, Keam B, Kim TM, Kim JH, Paeng JC, Kwon SK, Hah JH, Kwon TK, Kim DW, Wu HG, Sung MW, Heo DS.

BMC Cancer. 2016 Feb 17;16:116. doi: 10.1186/s12885-016-2147-y.

30.

Validity and reliability of the Korean version of the Speech Handicap Index in patients with oral cavity cancer.

Park SS, Choi SH, Hong JA, Hong YH, Jeong NG, Lee SY, Sung MW, Hah JH.

Int J Oral Maxillofac Surg. 2016 Apr;45(4):433-9. doi: 10.1016/j.ijom.2015.11.006. Epub 2015 Dec 15.

PMID:
26701323
31.

Identification of genomic mutations associated with clinical outcomes of induction chemotherapy in patients with head and neck squamous cell carcinoma.

Ock CY, Son B, Keam B, Lee SY, Moon J, Kwak H, Kim S, Kim TM, Jeon YK, Kwon SK, Hah JH, Lee SH, Kwon TK, Kim DW, Wu HG, Sung MW, Heo DS.

J Cancer Res Clin Oncol. 2016 Apr;142(4):873-83. doi: 10.1007/s00432-015-2083-2. Epub 2015 Dec 16.

PMID:
26677030
32.

Changes of Clinicopathologic Characteristics and Survival Outcomes of Anaplastic and Poorly Differentiated Thyroid Carcinoma.

Lee DY, Won JK, Lee SH, Park DJ, Jung KC, Sung MW, Wu HG, Kim KH, Park YJ, Hah JH.

Thyroid. 2016 Mar;26(3):404-13. doi: 10.1089/thy.2015.0316. Epub 2015 Dec 14.

PMID:
26541309
33.

Intramuscular Hemangioma in the Anterior Scalene Muscle Diagnosed by Core Needle Biopsy.

Cho JK, Cha W, Sung MW.

Clin Exp Otorhinolaryngol. 2015 Sep;8(3):298-301. doi: 10.3342/ceo.2015.8.3.298. Epub 2015 Aug 13.

34.

A Randomized, Multicenter, Phase II Study of Cetuximab With Docetaxel and Cisplatin as Induction Chemotherapy in Unresectable, Locally Advanced Head and Neck Cancer.

Lee KW, Koh Y, Kim SB, Shin SW, Kang JH, Wu HG, Sung MW, Keam B, Kim DW, Kim TM, Kim KH, Kwon TK, Hah JH, Kim IA, Ahn SH, Yoon DH, Lee SW, Kim SY, Nam SY, Jung KY, Baek SK, Hong SH, Lee SH, Heo DS.

Oncologist. 2015 Oct;20(10):1119-20. doi: 10.1634/theoncologist.2015-0208. Epub 2015 Aug 24.

35.

Study of Development for RFID System to Hospital Environment.

Hong SK, Sung MW.

Stud Health Technol Inform. 2015;216:904.

PMID:
26262206
36.

Prognostic factors of locally invasive well-differentiated thyroid carcinoma involving the trachea.

Kim H, Jung HJ, Lee SY, Kwon TK, Kim KH, Sung MW, Hun Hah J.

Eur Arch Otorhinolaryngol. 2016 Jul;273(7):1919-26. doi: 10.1007/s00405-015-3724-4. Epub 2015 Jul 22.

PMID:
26198285
37.

VEGF and Ki-67 Overexpression in Predicting Poor Overall Survival in Adenoid Cystic Carcinoma.

Park S, Nam SJ, Keam B, Kim TM, Jeon YK, Lee SH, Hah JH, Kwon TK, Kim DW, Sung MW, Heo DS, Bang YJ.

Cancer Res Treat. 2016 Apr;48(2):518-26. doi: 10.4143/crt.2015.093. Epub 2015 Jul 14.

38.

Postoperative biochemical remission of serum calcitonin is the best predictive factor for recurrence-free survival of medullary thyroid cancer: a large-scale retrospective analysis over 30 years.

Jung KY, Kim SM, Yoo WS, Kim BW, Lee YS, Kim KW, Lee KE, Jeong JJ, Nam KH, Lee SH, Hah JH, Chung WY, Yi KH, Park DJ, Youn YK, Sung MW, Cho BY, Park CS, Park YJ, Chang HS.

Clin Endocrinol (Oxf). 2016 Apr;84(4):587-97. doi: 10.1111/cen.12852. Epub 2015 Jul 30.

PMID:
26175307
39.

Locoregionally advanced nasopharyngeal carcinoma treated with intensity-modulated radiotherapy plus concurrent weekly cisplatin with or without neoadjuvant chemotherapy.

Wee CW, Keam B, Heo DS, Sung MW, Won TB, Wu HG.

Radiat Oncol J. 2015 Jun;33(2):98-108. doi: 10.3857/roj.2015.33.2.98. Epub 2015 Jun 30.

40.

Evaluation of the prevalence of and factors associated with laryngeal diseases among the general population.

Hah JH, Sim S, An SY, Sung MW, Choi HG.

Laryngoscope. 2015 Nov;125(11):2536-42. doi: 10.1002/lary.25424. Epub 2015 Jul 7.

PMID:
26154733
41.

Analysis of various risk factors predisposing subjects to allergic rhinitis.

An SY, Choi HG, Kim SW, Park B, Lee JS, Jang JH, Sung MW.

Asian Pac J Allergy Immunol. 2015 Jun;33(2):143-51. doi: 10.12932/AP0554.33.2.2015.

42.

Effect of Celecoxib on Survival of Mobile Tongue Cancer.

Lee DY, Lim JH, Kim YJ, Kim SD, Park SW, Kwon SK, Hah JH, Kwon TK, Kim KH, Kim YH, Sung MW.

Anticancer Res. 2015 Jul;35(7):4235-41.

PMID:
26124384
43.

Effect of induction chemotherapy on survival in locally advanced head and neck squamous cell carcinoma treated with concurrent chemoradiotherapy: Single center experience.

Ock CY, Keam B, Lim Y, Kim TM, Lee SH, Kwon SK, Hah JH, Kwon TK, Kim DW, Wu HG, Sung MW, Heo DS.

Head Neck. 2016 Feb;38(2):277-84. doi: 10.1002/hed.23891. Epub 2015 Jun 18.

PMID:
26104823
44.

Efficacy and Safety of Radiofrequency Ablation for Treatment of Locally Recurrent Thyroid Cancers Smaller than 2 cm.

Kim JH, Yoo WS, Park YJ, Park DJ, Yun TJ, Choi SH, Sohn CH, Lee KE, Sung MW, Youn YK, Kim KH, Cho BY.

Radiology. 2015 Sep;276(3):909-18. doi: 10.1148/radiol.15140079. Epub 2015 Apr 3.

PMID:
25848897
45.

Modified Sistrunk operation: New concept for management of thyroglossal duct cyst.

Ryu YJ, Kim DW, Jeon HW, Chang H, Sung MW, Hah JH.

Int J Pediatr Otorhinolaryngol. 2015 Jun;79(6):812-6. doi: 10.1016/j.ijporl.2015.03.001. Epub 2015 Mar 10.

PMID:
25829321
46.

Novel experimental rabbit model of anterior glottic web formation.

Kwon SK, Kim DW, Ryu YJ, Kim SY, Chang H, Sung MW, Hah JH.

Acta Otolaryngol. 2015 Aug;135(8):840-5. doi: 10.3109/00016489.2015.1028594. Epub 2015 Mar 31.

PMID:
25828378
47.

Long-Term Outcome of Definitive Radiotherapy for Early Glottic Cancer: Prognostic Factors and Patterns of Local Failure.

Lim YJ, Wu HG, Kwon TK, Hah JH, Sung MW, Kim KH, Park CI.

Cancer Res Treat. 2015 Oct;47(4):862-70. doi: 10.4143/crt.2014.203. Epub 2015 Feb 13.

48.

Prediction of extrathyroidal extension using ultrasonography and computed tomography.

Lee DY, Kwon TK, Sung MW, Kim KH, Hah JH.

Int J Endocrinol. 2014;2014:351058. doi: 10.1155/2014/351058. Epub 2014 Nov 27.

49.

Increasing thyroid cancer rate and the extent of thyroid surgery in Korea.

Sung MW, Park B, An SY, Hah JH, Jung YH, Choi HG.

PLoS One. 2014 Dec 3;9(12):e113464. doi: 10.1371/journal.pone.0113464. eCollection 2014.

50.

Chronic thalidomide and chemoembolization for hepatocellular carcinoma.

Wu J, Ng J, Christos PJ, Goldenberg AS, Sparano J, Sung MW, Hochster HS, Muggia FM.

Oncologist. 2014 Dec;19(12):1229-30. doi: 10.1634/theoncologist.2014-0283. Epub 2014 Oct 31.

Supplemental Content

Support Center